BlackRock Health Sciences Trust (NYSE:BME) Stake Boosted by Raymond James & Associates

Raymond James & Associates increased its stake in BlackRock Health Sciences Trust (NYSE:BME) by 3.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,673 shares of the company’s stock after purchasing an additional 1,375 shares during the quarter. Raymond James & Associates’ holdings in BlackRock Health Sciences Trust were worth $1,646,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. AdvisorNet Financial Inc purchased a new position in BlackRock Health Sciences Trust during the 3rd quarter valued at about $31,000. Stonebridge Capital Advisors LLC purchased a new position in BlackRock Health Sciences Trust during the 3rd quarter valued at about $31,000. Pathstone Family Office LLC purchased a new position in BlackRock Health Sciences Trust during the 4th quarter valued at about $252,000. JPMorgan Chase & Co. purchased a new position in BlackRock Health Sciences Trust during the 1st quarter valued at about $115,000. Finally, PNC Financial Services Group Inc. grew its stake in BlackRock Health Sciences Trust by 360.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,628 shares of the company’s stock valued at $166,000 after acquiring an additional 2,840 shares in the last quarter.

BlackRock Health Sciences Trust Stock Down 0.3 %

NYSE:BME opened at $38.74 on Friday. BlackRock Health Sciences Trust has a fifty-two week low of $35.53 and a fifty-two week high of $43.20. The stock’s 50-day moving average is $41.25 and its two-hundred day moving average is $39.99.

BlackRock Health Sciences Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be paid a $0.213 dividend. The ex-dividend date of this dividend is Friday, April 12th. This represents a $2.56 annualized dividend and a dividend yield of 6.60%.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.